Navigation Links
Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
Date:3/8/2011

BEVERLY, Mass., March 8, 2011 /PRNewswire/ -- Cellceutix Corporation (Pink Sheets: CTIX) today disclosed that it has entered into a Confidential Disclosure Agreement (CDA) pertaining to its anti-cancer drug, Kevetrin™, with one of the world's largest pharmaceutical companies.

Cellceutix CEO, Leo Ehrlich, commented, "It's relatively uncommon for big pharma to be signing a CDA on a compound before clinical trials are underway.  The process begins with Cellceutix providing non-confidential information to the other party.  If after review of the materials the interest remains high, they will request to enter into a CDA.   We are glad that their interpretation of the Kevetrin™ studies was sufficient to warrant entering into a CDA with Cellceutix."  Mr. Ehrlich continued, "Signing a CDA does not mean a licensing deal or other transaction is imminent and makes no assumptions that it ever will.  But, conversely, a deal won't ever happen without first signing a CDA.  At Cellceutix, we are focused on moving our compounds toward clinical trials and maximizing shareholders' value.  This agreement is one more step in that process."

Cellceutix has previously reported that in animal studies Kevetrin™ has shown potent anti-tumor activity against many different cancers including lung, breast and colon cancers as well as leukemia and various strains for which current drugs are ineffective ("drug-resistant cancers").  Data released over the last week by Cellceutix has also shown that Kevetrin™ demonstrates characteristics that are seen as highly desirable in a new chemotherapy as it has not only shown to be non-genotoxic, but also reactivates p53, the "Guardian Angel Protein."    

About Cellceutix

Cellceutix Corporation is a preclinical cancer, anti-inflammatory and autism drug developer. 
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
2. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
3. Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results
4. Cumberland Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
5. RBC Life Sciences Reports Sales and Earnings Growth in 2010
6. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results
7. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
8. IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter
9. China Pharma Holdings, Inc. Reports Full Year 2010 Financial Results
10. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Assured Pharmacy Reports Same Store Sales for the Month of December 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 Moerae Matrix, a clinical ... that target inflammation and fibrosis, today announced the ... as Chief Medical Officer. Dr. ... and programs, which include a pipeline of therapies ... conditions.  Bill is an accomplished strategist and scientist ...
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
(Date:7/6/2015)... July 6, 2015   Cepheid (Nasdaq: CPHD ... for its 2015 second quarter ended June 30, 2015 ... the market. The Company will host a ... July 23, 2015, to discuss the results.  To access ... http://ir.cepheid.com at least 15 minutes before the scheduled ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... , , THOUSAND OAKS, Calif., Jan. 7 Amgen ... JP Morgan Global Healthcare Conference at 8:00 a.m. Pacific Time ... in San Francisco, Calif. Amgen Chairman and CEO Kevin ... presentation will be available over the Internet and can be ...
... , , TUCSON, Ariz., Jan. 7 ... Fletcher McCusker, Chairman and Chief Executive Officer, is scheduled to present ... First 2010 Micro Cap Conference on Monday, January 11, 2010 at ... is scheduled for 1:50 p.m. ET. , On Thursday, ...
Cached Medicine Technology:Amgen to Present at the 28th Annual JP Morgan Healthcare Conference 2Providence Service Corporation to Present at the Sidoti & Company, LLC Micro Cap Conference on Monday, January 11th and at the CJS Securities 'New Ideas for the New Year' Conference on Thursday, January 14th 2
(Date:7/6/2015)... ... July 06, 2015 , ... Orthopaedic & Spine Center ... case using SpineFrontier’s® PedFuse® REmind® Screws. The operation took place on Tuesday, June ... procedure was an L5-S1 posterior lumbar interbody fusion on a 69 year old, ...
(Date:7/6/2015)... ... ... Thanks to donations and a generous grant from the GAR Foundation, Senior ... patients and adult day center participants. , The Music & Memory program is committed ... families and volunteers. Music & Memory is a non-profit organization that helps provide patients ...
(Date:7/5/2015)... ... July 06, 2015 , ... Security Life Insurance ... announce the next generation of PrimeStar Individual Dental Insurance. Beginning now, enhancements include ... network options—Maximum Allowable Charge (MAC) and usual, customary and reasonable (UCR). , ...
(Date:7/5/2015)... ... ... Women's Excellence in Wellness, powered by Movestrong announces parent/child fitness classes this summer ... want their children to stay active as well as spend time with their child ... at 4:30pm. Questions? Call 248-601-6683. Women’s Excellence in Wellness, powered by Movestrong is ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special ... months of unlimited classes for just $65. Student ID is needed at registration. , ... in Lake Orion. , Women’s Excellence is the most comprehensive obstetric ...
Breaking Medicine News(10 mins):Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... -- A new study suggests that many mothers of overweight ... overfeeding, researchers say. "Mothers of overweight toddlers were more ... children] to accurately perceive their child,s body size," wrote a ... School of Medicine. Part of the problem, the researchers ...
... -- A new study finds that heart attack survivors who live close ... during a 10-year span. U.S. researchers looked at more than 3,500 ... those who lived less than about 330 feet from a major road ... who lived about 3,300 feet or more away. Patients who ...
... exposure to the plastic additive bisphenol A, or BPA, alters ... evidence that the chemical can be causing health problems in ... "Previous studies in mice have demonstrated that low doses ... subtle changes increase the risk of cancer in the adult," ...
... is colonised by E. coli bacteria early in life ... reveals a study of infants carried out at the Sahlgrenska Academy ... gut outnumber the cells in our bodies by a factor of ... the maturation of the immune system. The normal bacterial flora in ...
... NEW YORK, N.Y. (May 7, 2012) Autism Speaks is ... the Modified Checklist for Autism in Toddlers, or M-CHAT. The ... 16 and 30 months of age to assess their risk ... Diana Robins, Ph.D. and Deborah Fein, Ph.D. and clinical psychologist ...
... -- Scientists who found a way to make white fat ... to new obesity treatments. Brown fat burns energy (preventing ... fat cells are associated with fat accumulation around organs in ... to an increased risk for diabetes and heart disease, the ...
Cached Medicine News:Health News:In Mom's Eyes, Overweight Toddler May Not Be 2Health News:Living Near Major Roads May Shorten Heart Attack Survival 2Health News:Researchers see BPA effects in monkey mammary glands 2Health News:Gut flora affects maturation of B cells in infants 2Health News:Automated autism screening tool available on Autism Speaks website 2
All Bovie LLETZ Loop and Square electrodes feature tungsten wire for superior shape and integrity throughout the excision procedure. They use a standard 3/32" (2.3 mm) shaft....
Extended modified needle - 25/box....
Split adult return electrode grounding pad with 2.8 m cable, 50/box....
7 1/2" Bayonet Monopolar Forceps, Ins., Serrated...
Medicine Products: